Protocols
Publications
Promoting the adoption of best practices and standards to enhance quality and reproducibility of stem cell research.
Lucia Selfa Aspiroz, Milena Mennecozzi, Laura Batlle, Barbara Corneo, Lyn Healy, Mark Kotter, Andreas Kurtz, Tenneille E. Ludwig, Christine Mummery, Martin Pera, Glyn N. Stacey, Carlos A. Tristan, and Maurice Whelan.
GUIDELINES AND REGULATION
ANNOTATED RULES FOR COST ACTIONS
As a network of scientists and academics, EuroStemCell provides independent, expert-reviewed information and road-tested educational resources on stem cells and their impact on society.
It also works with people affected by conditions, educators, regulators, media, healthcare professionals and policymakers to foster engagement and develop material that meets their needs.
As service to the field, the ISSCR develops guidelines that address the international diversity of cultural, political, legal, and ethical issues associated with stem cell research and its translation to medicine. The guidelines maintain and underscore widely shared principles in science that call for rigor, oversight, and transparency in all areas of practice. Adherence to these principles provides assurance that stem cell research is conducted with scientific and ethical integrity and that new therapies are evidence-based.
Responding to advances in science, the guidelines were updated in 2021 to encompass a broader and more expansive scope of research and clinical endeavor while maintaining the fundamental principles of the research and application. The 2021 guidelines include new recommendations to address the recent scientific advances involving embryos, stem cell-based embryo models, chimeras, organoids, and genome editing.
The ISCBI was initiated in 2007 with funding from the International Stem Cell Forum to create a global network of stem cell banks, both by coordinating existing pluripotent stem cell banks and also supporting those who are setting up new stem cell resource centres.
hPSCreg® offers the research community, legislators, regulators and the general public at large an in-depth overview on the current status of human pluripotent stem cell (hPSC) research.
The European Bank for induced pluripotent Stem Cells (EBiSC) is a centralised, not-for-profit iPSC bank providing researchers across academia and industry with access to scalable, cost-efficient and consistent, high quality iPSC lines and derived products for new medicines development.